← back to search

Kim Pearce

Newcastle University · GB
Area of research
Hematology · Cancer Research
Research interest
Research focused on Single-nucleotide polymorphism and European union, with related work in Cohort, Oncology, Haplotype. Notable publications include 'Regulation of advanced therapy medicinal products in Europe and the role of academia', 'Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease', and 'Predicting survival using clinical risk scores and non-HLA immunogenetics'.
h-index
citations
128
works
5
NIH funding
primary concept
email

Recent publications

Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease
Frontiers in Immunology 2021cited by 17position: middledoi
The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantation
International Journal of Immunogenetics 2018cited by 5position: middledoi
Impact of genomic risk factors on survival after haematopoietic stem cell transplantation for patients with acute leukaemia
International Journal of Immunogenetics 2016cited by 5position: firstdoi
Predicting survival using clinical risk scores and non-HLA immunogenetics
Bone Marrow Transplantation 2015cited by 14position: middledoi
Regulation of advanced therapy medicinal products in Europe and the role of academia
Cytotherapy 2013cited by 87position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Hildegard Greinix · Medical College of Wisconsin5 papers (2013–2021)Anne M. Dickinson · Newcastle University5 papers (2013–2021)Ernst Holler · Polyclinic Medical Center4 papers (2015–2021)Jean Norden · Newcastle University4 papers (2015–2021) · 3 papers (2015–2018)Matthew Collin · Royal Victoria Infirmary3 papers (2015–2021)Daniel Wolff · Polyclinic Medical Center3 papers (2015–2018) · 3 papers (2015–2018)Antoine Toubert · The University of Western Australia2 papers (2015–2016)Vanderson Rocha · Fundação Pró-Sangue Hemocentro de São Paulo2 papers (2015–2018)Gèrard Socié · Institut de Psychiatrie et Neurosciences de Paris2 papers (2015–2018)Udo Holtick · Centrum für Integrierte Onkologie2 papers (2015–2016)Yesilda Balavarca · Biostatistical Consulting (United States)2 papers (2015–2016)Eva M. Weissinger · Medizinische Hochschule Hannover2 papers (2013–2021)Heike Bickeböller · National Center for Tumor Diseases2 papers (2015–2016) · 2 papers (2015–2016)Graham Jackson · Newcastle upon Tyne Hospitals NHS Foundation Trust2 papers (2015–2016)Petr Sedláček · Charles University2 papers (2015–2016)Clare Lendrem · NIHR Newcastle Biomedical Research Centre1 papers (2021–2021)Mark W. Lowdell · University College London1 papers (2013–2013)